Tower Research Capital LLC (Trc) Centogene N.V. Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.06 - $4.25 $834 - $1,721	-405 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$3.3 - $5.44 $1,811 - $2,986	-549 Reduced 57.55%	405 $2,000
Q4 2021 Feb 14, 2022	BUY	$4.56 - $10.56 $4,332 - $10,032	950 Added 23750.0%	954 $5,000
Q3 2021 Nov 15, 2021	SELL	$9.9 - $11.72 $504 - $597	-51 Reduced 92.73%	4 $0
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.93 $7,522 - $10,783	-834 Reduced 93.81%	55 $1,000

Q1 2021 May 17, 2021	SELL	$10.56 - $13.94 $7,518 - $9,925	-712 Reduced 44.47%	889 $11,000
Q4 2020 Feb 16, 2021	SELL	$9.44 - $13.3 $31,312 - $44,116	-3,317 Reduced 67.45%	1,601 $18,000
Q3 2020 Nov 16, 2020	BUY	$9.3 - $25.16 $32,540 - $88,034	3,499 Added 246.58%	4,918 $47,000
Q2 2020 Aug 13, 2020	BUY	$15.99 - $22.88 $22,689 - $32,466	1,419 New	1,419 $33,000
Q1 2020 May 15, 2020	SELL	$9.76 - $23.8 $3,054 - $7,449	-313 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$8.1 - $14.6 $2,535 - $4,569	313 New	313 $3,000

2.14M

Ticker CNTG
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,081,600
Market Cap $10.3M
Description
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.